DE69332959D1 - Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen - Google Patents

Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen

Info

Publication number
DE69332959D1
DE69332959D1 DE69332959T DE69332959T DE69332959D1 DE 69332959 D1 DE69332959 D1 DE 69332959D1 DE 69332959 T DE69332959 T DE 69332959T DE 69332959 T DE69332959 T DE 69332959T DE 69332959 D1 DE69332959 D1 DE 69332959D1
Authority
DE
Germany
Prior art keywords
mesothelial cells
peritoneal dialysis
solutions
peritoneal
reduce damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332959T
Other languages
English (en)
Other versions
DE69332959T2 (de
Inventor
Andrzej Breborowicz
Dimirios G Oreopulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of DE69332959D1 publication Critical patent/DE69332959D1/de
Application granted granted Critical
Publication of DE69332959T2 publication Critical patent/DE69332959T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69332959T 1992-02-04 1993-02-04 Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen Expired - Fee Related DE69332959T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83072192A 1992-02-04 1992-02-04
US830721 1992-02-04

Publications (2)

Publication Number Publication Date
DE69332959D1 true DE69332959D1 (de) 2003-06-12
DE69332959T2 DE69332959T2 (de) 2004-05-13

Family

ID=25257564

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69320078T Expired - Fee Related DE69320078T2 (de) 1992-02-04 1993-02-04 Peritonealdialyselösungen die mindestens ein Dipeptid enthalten
DE69332959T Expired - Fee Related DE69332959T2 (de) 1992-02-04 1993-02-04 Lösungen für die Peritonealdialyse und deren Verwendung zum Verringern von Schädigungen an mesothelialen Zellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69320078T Expired - Fee Related DE69320078T2 (de) 1992-02-04 1993-02-04 Peritonealdialyselösungen die mindestens ein Dipeptid enthalten

Country Status (8)

Country Link
US (2) US5597805A (de)
EP (2) EP0804931B1 (de)
JP (1) JP3262620B2 (de)
AT (2) ATE239503T1 (de)
DE (2) DE69320078T2 (de)
DK (1) DK0555087T3 (de)
ES (1) ES2121941T3 (de)
GR (1) GR3027714T3 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
DE69320078T2 (de) * 1992-02-04 1999-03-25 Baxter Int Peritonealdialyselösungen die mindestens ein Dipeptid enthalten
ES2185646T3 (es) * 1992-12-22 2003-05-01 Baxter Int Soluciones de aminoacido mejoradas para el tratamiento de pacientes de dialisis peritoneal.
CA2155910C (en) * 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
EP1009452A4 (de) 1997-08-07 2004-03-31 Ajay Gupta Wasserlösliche vitamine und nährstoffe enthaltende dialyselösung
DE69929550T8 (de) 1998-05-21 2006-12-28 Nipro Corp. Albumin enthaltende Lösung für die Peritonealdialyse
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
DE60039978D1 (de) 1999-04-26 2008-10-02 Edwards Lifesciences Ag Substitutions-infusionflüssigkeit und zitratanticoagulation
US6627164B1 (en) 2000-11-28 2003-09-30 Renal Solutions, Inc. Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
US7033498B2 (en) * 2000-11-28 2006-04-25 Renal Solutions, Inc. Cartridges useful in cleaning dialysis solutions
US6878283B2 (en) * 2001-11-28 2005-04-12 Renal Solutions, Inc. Filter cartridge assemblies and methods for filtering fluids
WO2003055481A1 (fr) * 2001-12-25 2003-07-10 Ajinomoto Co., Inc. Inhibiteurs de fibrose des organes
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
WO2009044765A1 (ja) * 2007-10-01 2009-04-09 Seikagaku Corporation 新規な低分子化コンドロイチン硫酸およびその用途
US8841262B2 (en) * 2009-03-31 2014-09-23 Cci Corporation Agent for inhibiting peritoneal membrane thickening
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
WO2015142624A1 (en) 2014-03-17 2015-09-24 Fresenius Medical Care Holdings, Inc. Cartridges useful in cleaning dialysis solutions
US10603421B2 (en) 2015-09-16 2020-03-31 Fresenius Medical Care Holdings, Inc. Cartridges useful in cleaning dialysis solutions
EP3352586A4 (de) 2015-09-21 2019-05-15 The Board Of Trustees Of The Leland Stanford Junior University Ernährungsbehandlung bei krebserkrankungen
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
EP3723772A4 (de) 2017-12-11 2021-09-08 Filtricine, Inc. Zusammensetzungen, verfahren, kits und systeme zur krebsbehandlung und stoffwechselinterventionstherapie
GB202202728D0 (en) * 2022-02-28 2022-04-13 Invizius Ltd Peritoneal fluid composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US4339433A (en) * 1981-01-09 1982-07-13 Baxter Travenol Laboratories, Inc. Additives for peritoneal dialysis solutions
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
US4761237A (en) * 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
US4886789A (en) * 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
JPS61247466A (ja) * 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
DE3683583D1 (de) * 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
US4976683A (en) * 1986-06-20 1990-12-11 Abbott Laboratories Peritoneal dialysis method
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
DE3812525C1 (de) * 1988-04-15 1989-06-22 Fresenius Ag, 6380 Bad Homburg, De
JPH02196724A (ja) * 1989-01-26 1990-08-03 Terumo Corp 腹膜透析液
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
DE69320078T2 (de) * 1992-02-04 1999-03-25 Baxter Int Peritonealdialyselösungen die mindestens ein Dipeptid enthalten

Also Published As

Publication number Publication date
GR3027714T3 (en) 1998-11-30
ES2121941T3 (es) 1998-12-16
DE69320078T2 (de) 1999-03-25
JP3262620B2 (ja) 2002-03-04
EP0555087A1 (de) 1993-08-11
DE69332959T2 (de) 2004-05-13
DE69320078D1 (de) 1998-09-10
JPH05345021A (ja) 1993-12-27
US5955450A (en) 1999-09-21
EP0804931B1 (de) 2003-05-07
DK0555087T3 (da) 1999-05-03
EP0804931A3 (de) 2001-04-11
ATE239503T1 (de) 2003-05-15
US5597805A (en) 1997-01-28
EP0555087B1 (de) 1998-08-05
ATE169223T1 (de) 1998-08-15
EP0804931A2 (de) 1997-11-05

Similar Documents

Publication Publication Date Title
ATE239503T1 (de) Lösungen für die peritonealdialyse und deren verwendung zum verringern von schädigungen an mesothelialen zellen
FR2639233B1 (fr) Agent d'hygiene en hemodialyse
US5284470A (en) Wearable, portable, light-weight artificial kidney
AU6951087A (en) Pump block for interfacing irradiation chamber to photoactivation patient treatment system
ATE156369T1 (de) Vorrichtung zum vermeiden einer hypotonie bei dialysepatienten
PT911043E (pt) Processo para a medicao de parametros de rendimento, de modulos de permuta de substancias e de energia
JP2005509496A (ja) 装着型持続的腎機能代替療法装置
DE69733826D1 (de) Behandlung von leukocyten durch photopheresis
DE59409509D1 (de) Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate als Angiotensin II Antagonisten
TR26748A (tr) SU VE N-METIL-MORFOLIN-N-OKSIT ICINDE SELüLOZ CÖZELTISI.
IE821162L (en) Dialysis solution
DE69624914T2 (de) Vorrichtung und verfahren für die biospezifische entfernung von heparin
ATE260091T1 (de) Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten
EP0839543A1 (de) Verfahren und Vorrichtung zur Desinfektion eines medizinischen Gerätes
DE69521388T2 (de) Verwendung von Glycosaminoglycanen zur Herstellung eines Arzneimittels zur Behandlung des chronischen Nierenversagens
ZA871410B (en) Zero insertion force socket for photoactivation patient treatment system
DE68903435D1 (de) Aminoketale, deren herstellung und deren verwendung als fungizides mittel.
DE69911843D1 (de) Hämodialysegerät
JPH0686810A (ja) 血液浄化装置
ATE127787T1 (de) Nitratoalkancarbonsäure-derivate und verfahren zu ihrer herstellung.
JPH0413145U (de)
ES2069499A1 (es) Procedimiento de envasado de compuestos y concentrados para utilizar en el tratamiento de la dialisis y hemodialisis.
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.
TH19226EX (th) การบำบัดรักษาความวิตกกังวลด้วยการช่วยเหลือของ (s)-(-)อัลฟา-เอทธิล-2-ออกโซ-1-ไพโรลิดีนอาเซตตามีด
TH19226A (th) การบำบัดรักษาความวิตกกังวลด้วยการช่วยเหลือของ (s)-(-)อัลฟา-เอทธิล-2-ออกโซ-1-ไพโรลิดีนอาเซตตามีด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee